374 related articles for article (PubMed ID: 30685842)
1. Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1
Tefera TW; Bartlett K; Tran SS; Hodson MP; Borges K
Mol Neurobiol; 2019 Aug; 56(8):5844-5855. PubMed ID: 30685842
[TBL] [Abstract][Full Text] [Related]
2. Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1
Tefera TW; Borges K
J Cereb Blood Flow Metab; 2019 Sep; 39(9):1710-1724. PubMed ID: 29553298
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine alleviates ALS-like pathology in hSOD1
Lu J; He AX; Jin ZY; Zhang M; Li ZX; Zhou F; Ma L; Jin HM; Wang JY; Shen X
Acta Pharmacol Sin; 2024 May; 45(5):926-944. PubMed ID: 38286832
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of complement C5a-C5a
Lee JD; Kumar V; Fung JN; Ruitenberg MJ; Noakes PG; Woodruff TM
Br J Pharmacol; 2017 Apr; 174(8):689-699. PubMed ID: 28128456
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.
Lee JD; Kamaruzaman NA; Fung JN; Taylor SM; Turner BJ; Atkin JD; Woodruff TM; Noakes PG
J Neuroinflammation; 2013 Sep; 10():119. PubMed ID: 24067070
[TBL] [Abstract][Full Text] [Related]
7. Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model.
Cai M; Lee SH; Yang EJ
Mol Neurobiol; 2019 Apr; 56(4):2394-2407. PubMed ID: 30030751
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
9. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1
Ravera S; Torazza C; Bonifacino T; Provenzano F; Rebosio C; Milanese M; Usai C; Panfoli I; Bonanno G
J Neurochem; 2019 Nov; 151(3):336-350. PubMed ID: 31282572
[TBL] [Abstract][Full Text] [Related]
10. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
[TBL] [Abstract][Full Text] [Related]
11. Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.
Lukas TJ; Luo WW; Mao H; Cole N; Siddique T
Mol Cell Proteomics; 2006 Jul; 5(7):1233-44. PubMed ID: 16571896
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1
Xu X; Yang Q; Liu Z; Zhang R; Yu H; Wang M; Chen S; Xu G; Shao Y; Le W
Neurobiol Dis; 2023 Jun; 181():106110. PubMed ID: 37001614
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the NAD
Harlan BA; Killoy KM; Pehar M; Liu L; Auwerx J; Vargas MR
Exp Neurol; 2020 May; 327():113219. PubMed ID: 32014438
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.
Martin LJ; Adams DA; Niedzwiecki MV; Wong M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359844
[TBL] [Abstract][Full Text] [Related]
15. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS.
Cacabelos D; Ramírez-Núñez O; Granado-Serrano AB; Torres P; Ayala V; Moiseeva V; Povedano M; Ferrer I; Pamplona R; Portero-Otin M; Boada J
Acta Neuropathol Commun; 2016 Jan; 4():3. PubMed ID: 26757991
[TBL] [Abstract][Full Text] [Related]
16. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
Meister S; Storck SE; Hameister E; Behl C; Weggen S; Clement AM; Pietrzik CU
J Cereb Blood Flow Metab; 2015 Jul; 35(7):1112-21. PubMed ID: 25853911
[TBL] [Abstract][Full Text] [Related]
17. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
18. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
López-González R; Kunckles P; Velasco I
Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis indicates the involvement of immunity and inflammation in the onset stage of SOD1-G93A mouse model of ALS.
Chen L; Wang N; Zhang Y; Li D; He C; Li Z; Zhang J; Guo Y
J Proteomics; 2023 Feb; 272():104776. PubMed ID: 36423857
[TBL] [Abstract][Full Text] [Related]
20. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
